This bit of bad news from the CDC prevention news sounds positive for Remune, and thus AGPH:
"Lack of T-Cell Proliferative Response to HIV-1 Antigens After 1
Year of Highly Active Antiretroviral Therapy in Early HIV-1
Disease [Research Letter]"
Lancet (10/10/98) Vol. 352, No. 9135, P. 1194; Plana, Montserrat;
Garcia, Felipe; Gallart, Teresa
A team of Spanish researchers investigated virus-specific CD4
T-cell helper responses in patients receiving highly active
antiretroviral therapy (HAART). The responses are not usually
detected in people with early HIV infection. CD4 T-cell
proliferation and response is associated with viremia control in
a few long-term non-progressors and in patients whose viremia is
controlled by HAART before seroconversion. The researchers
divided 159 asymptomatic HIV-1 infected people into different
groups receiving triple therapy, double therapy, or no therapy.
They measured proliferative response to pokeweed mitogen, recall
antigens, tetanus toxoid, a ubiquitous antigen cytomegalovirus,
and three HIV-1 recombinant proteins. They found that there was
a lack of specific T-cell response to the HIV-1 proteins in all
of the individuals and that other responses were similar as well.
The authors note that the data indicates, "HAART alone will most
likely not be enough to restore HIV-1-specific T-cell helper
responses in people with chronic HIV-1 infection," and they
suggest that other therapeutic strategies be investigated. |
